Advances in Autoimmune Hemolytic Anemia: Targeting the Complement Cascade in Cold Agglutinin Disease

Review the latest clinical trial data, newly approved indications, and emerging novel targeted therapies for the management of cold agglutinin disease with downloadable slides and on-demand webcast from a live expert-led symposium during the ASH annual meeting, together with a frequently asked questions commentary with expert’s perspectives on audience questions from the live program.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Sanofi.

Sanofi